Modified coronavirus structural protein
US-2024226271-A1 · Jul 11, 2024 · US
US10059956B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10059956-B2 |
| Application number | US-201314372232-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 16, 2013 |
| Priority date | Jan 17, 2012 |
| Publication date | Aug 28, 2018 |
| Grant date | Aug 28, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a polynucleotide encoding a protein having activity that transfers a sugar to the hydroxyl group at the 4′-position of a flavone, wherein the polynucleotide is selected from the group consisting of: (a) a polynucleotide composed of the base sequence of SEQ ID NO: 1; (b) a polynucleotide that hybridizes under stringent conditions with a polynucleotide composed of a base sequence complementary to the base sequence of SEQ ID NO: 1; (c) a polynucleotide encoding a protein composed of the amino acid sequence of SEQ ID NO: 2; and, (d) a polynucleotide encoding a protein composed of an amino acid sequence in which one or a plurality of amino acids have been deleted, substituted, inserted and/or added in the amino acid sequence of SEQ ID NO:2.
Opening claim text (preview).
The invention claimed is: 1. A recombinant expression vector comprising a polynucleotide operably linked to a heterologous promoter, wherein the polynucleotide is selected from the group consisting of the following (a) to (d): (a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1; (b) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO: 2; (c) a polynucleotide encoding a protein having one to five amino acids deleted, substituted, or inserted in the amino acid sequence of SEQ ID NO: 2, and having an activity of transferring a sugar group to the hydroxyl group at the 4′-position of a flavone; and, (d) a polynucleotide encoding a protein having an amino acid sequence identity of 95% or more with SEQ ID NO: 2, and having an activity of transferring a sugar group to the hydroxyl group at the 4′-position of a flavone. 2. A non-human host transformed by the recombinant expression vector of claim 1 . 3. A plant transformed by the recombinant expression vector of claim 1 , a progeny thereof, a portion of the transformed plant or the progeny, or a tissue of the transformed plant or the progeny, wherein each of the plant, the progeny, the portion, and the tissue comprises the recombinant vector. 4. A portion of the plant of claim 3 , wherein the portion is a cut flower. 5. A processed cut flower obtained from the cut flower of claim 4 . 6. A method for producing a protein having an activity of transferring a sugar group to the hydroxyl group at the 4′-position of a flavone, comprising the following steps: culturing or growing the non-human host of claim 2 , and harvesting, from the non-human host, the protein having the activity of transferring a sugar group to the hydroxyl group at the 4′-position of a flavone. 7. A method for producing a flavone in which a sugar group has been added to the hydroxyl group at the 4′-position thereof, comprising the following steps: culturing or growing the non-human host of claim 2 , and harvesting, from the non-human host, the flavone in which a sugar group has been added to the hydroxyl group at the 4′-position thereof. 8. The recombinant expression vector of claim 1 , wherein the heterologous promoter is selected from the group consisting of a bacterial promoter, a yeast promoter, a filamentous fungi promoter, and a promoter for animal cell hosts. 9. The recombinant expression vector of claim 1 , wherein the heterologous promoter constitutively expresses a gene in plant cells. 10. The recombinant expression vector of claim 9 , wherein the heterologous promoter is selected from the group consisting of cauliflower mosaic virus 35S RNA promoter, rd29A gene promoter, rbcS promoter, and mac-1 promoter. 11. The recombinant expression vector of claim 1 , wherein the heterologous promoter specifically expresses a gene in a plant tissue.
Antineoplastic agents · CPC title
involving pigment biosynthesis · CPC title
Glycosides, e.g. rutin · CPC title
produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title
for the production of primary gene products, e.g. pharmaceutical products, interferon · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.